Business
Bionano Genomics Announces Extensive Lineup of Content at Association for Molecular Pathology (AMP) Annual Meeting Featuring OGM Utility Across Broad Range of Research Applications
Dr. Alka Chaubey, chief medical officer at Bionano, Dr. Nikhil Sahajpal, Greenwood Genetic Center, Dr. Rashmi Kanagal-Shamanna, MD Anderson Cancer Center, and
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"Dr. Alka Chaubey, chief medical officer at Bionano, Dr. Nikhil Sahajpal, Greenwood Genetic Center, Dr. Rashmi Kanagal-Shamanna, MD Anderson Cancer Center, and Dr. Adam Smith, University Health Network will host a sponsored vendor presentation on studies that include multiple types of hematological malignancies, and highlight the benefits of combining optical genome mapping (OGM) with next generation sequencing (NGS) to maximize actionable resultsA scientific presentation featuring Dr. Chaubey, Dr. Kanagal-Shamanna, Dr. Ravindra Kolhe, Augusta University, and Dr. Christopher Lum, Queens Medical Center will cover methodologies for homologous recombination deficiency (HRD) assessment, including NGS, microarray and OGM, as well as bioinformatics approaches for analysis of data across solid tumors and hematological malignanciesA plenary session will feature Dr. Smith delivering a presentation on the implementation of long-read sequencing (LRS) and OGM for cytogenetic research, and will be immediately followed by a panel discussion on the use of new tools, including OGM, in next generation cytogenomics, featuring Dr. Smith, Dr. Eric Duncavage, Washington University School of Medicine, Dr. Yassmine Akkari, Nationwide Children’s Hospital and Dr. Robert Hasserjian, Massachusetts General HospitalEleven scientific posters featuring results from OGM applications in prenatal and postnatal analysis, solid tumor, and hematological malignancy research will be presented at the conference SAN DIEGO, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the Association for Molecular Pathology (AMP) Annual Meeting and Expo 2022 with a broad range of content covering optical genome mapping’s (OGM) utility for research applications including prenatal and postnatal analysis, genetic disease and hematological malignancies. AMP’s Annual Meeting brings together industry, medical, and academic professionals to discuss advances in the field of molecular diagnostics. The AMP conference will be held November 1-5, 2022, in Phoenix, Arizona. Scientific presentations and poster sessions from Bionano and collaborators include: SessionTitlePresenterPresentedCorporate WorkshopMaximizing Detection of Pathogenic Structural Variants Across Hematological Malignancies with Optical Genome MappingChaubey A., Sahajpal...